5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer

Journal of Dermatology

Volumn 38, Issue 8, 2011, Pages 748-754

  Hirata, Yui ^a   Koga, Sumie ^a   Fukui, Nao ^a   Yu, Akitoshi ^a   Koshida, Saya ^a   Kosaka, Yukako ^a   Kurokawa, Teruo ^a   Moriwaki, Shinichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

5 aminolevulinic acid; actinic keratosis; Bowen's disease; photodynamic therapy; skin cancer; Super Lizer

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BOWEN DISEASE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LASER; MALE; PHOTODYNAMIC THERAPY; SUPERFICIAL CANCER; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BOWEN'S DISEASE; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 79961089531     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01102.x     Document Type: Article

References (20)

1. Kennedy JC, Pottier RH, Pross DC,. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol 1990; 6: 143-148.
2. Salim A, Leman JA, MnColl JH, Moore JV, Mackie RM,. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003; 148: 539-543. (Pubitemid 36461334)
3. Kuwa HA, Yong-Gee SA, Seed PT, Markey AC, Barlow RJ,. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratosis. J Am Acad Dermatol 1999; 41: 414-418. (Pubitemid 29418508)
4. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM,. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-771. (Pubitemid 26375895)
5. Ohgari Y, Nakayasu Y, Kitajima S, et al. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem Pharmacol 2005; 71: 42-49. (Pubitemid 41713525)
6. Pass HI,. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993; 85: 443-456. (Pubitemid 23084089)
7. Dolphin D,. Photomedicine and photodynamic therapy. Can J Chem 1994; 72: 1005-1013.
8. Nakaseko H, Kobayashi M, Akita Y, Tamada Y, Matsumoto Y,. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol 2003; 148: 122-127. (Pubitemid 36114872)
9. Nakano A, Tamada Y, Watanabe D, et al. A pilot study to assess the efficacy of photodynamic therapy for Japanese patients with actinic keratosis in relation to lesion size and histological severity. Photodermatol Photoimmunol Photomed 2009; 25: 37-40.
10. Miller DL, Weinstock MA,. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30: 774-778. (Pubitemid 24157120)
11. Green A,. Changing patterns in indence of non-melanoma skin cancer. Epithelial Cell Biol 1992; 1: 47-51.
12. Giles CG, Marks R, Foley P,. Incidence of non-melanoma skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296: 13-17. (Pubitemid 18025276)
13. Ishihara K,. Statistics and prognostic factors for malignant skin tumors in Japan. Skin Cancer 2005; 20: 234-147.
14. Szeimies RM,. Epidemiology of actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Presented at the International Skin Cancer Conference, Zurich, July 22-24, 2004.
15. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigatorblinded, phase 3, multicenter trials. Arch Dermatol 2004; 140: 41-46. (Pubitemid 38090269)
16. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM,. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-772.
17. Szeimies RM, Morton CA, Sidoroff A, Braathen LR,. Photodynamic therapy for non-melanoma skin cancer. Acta Derm Venereol 2005; 85: 483-490. (Pubitemid 43087284)
18. Kobayashi M, Nakaseko H, Akita Y, Tamada Y, Matsumoto Y,. A study of treatment outcome results after using topical 5-aminolevulinic acid-based photodynamic therapy on superficial cutaneous carcinoma. Jpn J Dermatol 2002; 112: 1577-1583.
19. Apalla Z, Sotiriou E, Chovarda E, Lefaki I, Devliotou-Panagiotidou D, Ioannides D,. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. a randomized placebo-controlled study. Br J Dermatol 2010; 162: 171-175.
20. Morton CA, Brown SB, Collons S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-567. (Pubitemid 34437765)